You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CHIR258, CHIR-258, CHIR 258, TKI258, TKI-258, TKI 258,

Showing 1 - 25 of 631
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of the Pancreas, Stage III Pancreatic Cancer, Stage IV Pancreatic Cancer Trial in Buffalo (dovitinib lactate,

Completed
  • Adenocarcinoma of the Pancreas
  • +3 more
  • dovitinib lactate
  • +5 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 20, 2022

Melanoma Trial in Louisville, Pittsburgh, Houston (TKI258)

Completed
  • Melanoma
  • Louisville, Kentucky
  • +2 more
Mar 9, 2021

Tumor, Cancer, Tumors Trial in United States (TKI258)

Completed
  • Neoplasm
  • +2 more
  • Scottsdale, Arizona
  • +3 more
Dec 17, 2020

Tumors, Cancer, Tumors Trial in United States (TKI258 (dovitinib))

Completed
  • Neoplasms
  • +2 more
  • TKI258 (dovitinib)
  • Duarte, California
  • +3 more
Dec 17, 2020

Prostate Cancer Trial in Houston (TK1258)

Completed
Has Results
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Aug 22, 2019

Hormone Refractory Prostate Cancer Trial in Seoul (TKI258)

Completed
  • Hormone Refractory Prostate Cancer
  • Seoul, Chongro-ku, Korea, Republic of
  • +1 more
Feb 16, 2021

Advanced Solid Malignancies Trial in Amsterdam (TKI258)

Completed
  • Advanced Solid Malignancies
  • Amsterdam, Netherlands
    Novartis Investigative Site
Dec 17, 2020

Advanced Solid Tumors Trial in Takatsuki, Hidaka (TKI258)

Completed
  • Advanced Solid Tumors
  • Takatsuki, Osaka, Japan
  • +1 more
Dec 17, 2020

Advanced Solid Tumors, Excluding Breast Cancer Trial in Worldwide (dovitinib (TKI258), fluvoxamine)

Completed
  • Advanced Solid Tumors, Excluding Breast Cancer
  • Bronx, New York
  • +5 more
Dec 17, 2020

Advanced Solid Tumors, Excluding Breast Cancer Trial in United States (caffeine, diclofenac, omeprazole)

Completed
  • Advanced Solid Tumors, Excluding Breast Cancer
  • Kansas City, Kansas
  • +4 more
Dec 17, 2020

Solid Tumors, Hepatic Impairment Trial in Worldwide (Dovitinib)

Completed
  • Solid Tumors
  • Hepatic Impairment
  • Los Angeles, California
  • +11 more
Dec 17, 2020

Advanced/ Metastatic Renal Cell Cancer Trial in Worldwide (TKI258)

Completed
  • Advanced/ Metastatic Renal Cell Cancer
  • San Francisco, California
  • +11 more
Dec 17, 2020

Urothelial Cancer Trial in Worldwide (TKI258)

Completed
  • Urothelial Cancer
  • La Jolla, California
  • +25 more
Dec 11, 2020

Advanced Solid Tumors, Excluding Breast Cancer Trial in United States (TKI258)

Completed
  • Advanced Solid Tumors
  • Excluding Breast Cancer
  • Duarte, California
  • +13 more
Dec 17, 2020

Solid Tumors Trial in Hospitalet de Llobregat, Fuenlabrada, Madrid (Dovitinib, Dovitinib + Paclitaxel)

Terminated
  • Solid Tumors
  • Hospitalet de Llobregat, Barcelona, Spain
  • +2 more
Apr 15, 2020

Relapsed or Refractory Multiple Myeloma Trial in Worldwide (TKI258)

Completed
  • Relapsed or Refractory Multiple Myeloma
  • Mobile, Alabama
  • +29 more
Dec 11, 2020

Gastrointestinal Stromal Tumors Trial in Seoul, (dovitinib)

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Seoul,, Korea, Republic of
    Asan Medical Center, University of Ulsan College of Medicine
Jan 6, 2020

Metastatic Breast Cancer Trial in Worldwide (TKI258)

Completed
  • Metastatic Breast Cancer
  • Bakersfield, California
  • +37 more
Dec 11, 2020

Breast Cancer Trial in Houston (Dovitinib)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jul 22, 2019

Gastric Cancer Trial in Seoul (Dovitinib)

Completed
  • Gastric Cancer
  • Seoul, Korea, Republic of
    Asan Medical Center
Jan 6, 2020

COVID-19 Trial in Seha (Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-09), Inactivated COVID-19 vaccine (Vero cells))

Active, not recruiting
  • COVID-19
  • Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-09)
  • Inactivated COVID-19 vaccine (Vero cells)
  • Seha, Abu Dhab, United Arab Emirates
    Sheikh Khalifa Medical City
Jan 31, 2023

Prostate Cancer Trial in Houston (Dovitinib, Abiraterone Acetate, Prednisone)

Terminated
Has Results
  • Prostate Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Feb 26, 2019

NSCLC Stage III, EGFR Positive NSCLC, Non-squamous Non-small-cell Lung Cancer Trial in Korea, Republic of (Lazertinib)

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • +2 more
  • Busan, Korea, Republic of
  • +12 more
Jan 17, 2023

Idiopathic Hypersomnia Trial in Worldwide (JZP-258, Placebo Oral Solution)

Completed
Has Results
  • Idiopathic Hypersomnia
  • Birmingham, Alabama
  • +62 more
Nov 18, 2021

Type 2 Diabetes Trial in Mannheim (ATR-258)

Recruiting
  • Type 2 Diabetes Mellitus
  • Mannheim, Germany
    CRS Clinical Research Services
Jun 4, 2022